Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1991 Aug;107(1):43–54. doi: 10.1017/s0950268800048664

Rubella in Europe.

A Galazka 1
PMCID: PMC2272032  PMID: 1879489

Full text

PDF
43

Images in this article

48Fig. 5
on p.48

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. M., May R. M. Two-stage vaccination programme against rubella. Lancet. 1983 Dec 17;2(8364):1416–1417. doi: 10.1016/s0140-6736(83)90939-x. [DOI] [PubMed] [Google Scholar]
  2. Andzhaparidze O. G., Desiatskova R. G., Chervonskii G. I., Aminova M. G., Termetchikova N. M. Seroépidemiologiia krasnukhi v SSS. Vopr Virusol. 1972 Jul-Aug;17(4):412–418. [PubMed] [Google Scholar]
  3. Böttiger M., Christenson B., Romanus V., Taranger J., Strandell A. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella. Br Med J (Clin Res Ed) 1987 Nov 14;295(6608):1264–1267. doi: 10.1136/bmj.295.6608.1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Böttiger M., Christenson B., Taranger J., Bergman M. Mass vaccination programme aimed at eradicating measles, mumps and rubella in Sweden: vaccination of schoolchildren. Vaccine. 1985 Jun;3(2):113–116. doi: 10.1016/0264-410x(85)90059-3. [DOI] [PubMed] [Google Scholar]
  5. Cockburn W. C. World aspects of the epidemiology of rubella. Am J Dis Child. 1969 Jul;118(1):112–122. doi: 10.1001/archpedi.1969.02100040114019. [DOI] [PubMed] [Google Scholar]
  6. De la Mata I., De Wals P. Policies for immunization against rubella in European countries. Eur J Epidemiol. 1988 Jun;4(2):175–180. doi: 10.1007/BF00144747. [DOI] [PubMed] [Google Scholar]
  7. Enders-Ruckle G. Seroepidemiology of rubella and reinfection. Am J Dis Child. 1969 Jul;118(1):139–142. doi: 10.1001/archpedi.1969.02100040141023. [DOI] [PubMed] [Google Scholar]
  8. Hinman A. R., Bart K. J., Orenstein W. A., Preblud S. R. Rational strategy for rubella vaccination. Lancet. 1983 Jan 1;1(8314-5):39–40. doi: 10.1016/s0140-6736(83)91572-6. [DOI] [PubMed] [Google Scholar]
  9. Imbs D., Rudnicka H., Diuwe A. Seroepidemiologiczne badania w kierunku rózyczki wśród ludności w Polsce. Przegl Epidemiol. 1985;39(2):193–198. [PubMed] [Google Scholar]
  10. Iorio A. M., Rivosecchi P., Fanelli M., Pitzurra M. Distribuzione degli anticorpi contro il virus della rosolia in un campione de popolazione famminile del comune di Perugia e resultati sierologici di un esperimento di vaccinazione antirosolia. Boll Ist Sieroter Milan. 1972 Sep-Dec;51(5):405–409. [PubMed] [Google Scholar]
  11. Kańtoch M., Imbs D. Postinfection and postvaccination antirubella immunity. Acta Virol. 1986 Sep;30(5):381–389. [PubMed] [Google Scholar]
  12. Knox E. G. Theoretical aspects of rubella vaccination strategies. Rev Infect Dis. 1985 Mar-Apr;7 (Suppl 1):S194–S197. doi: 10.1093/clinids/7.supplement_1.s194. [DOI] [PubMed] [Google Scholar]
  13. Krohn E. F. Epidemiological aspects of rubella in Europe. Int J Epidemiol. 1972 Autumn;1(3):267–270. doi: 10.1093/ije/1.3.267. [DOI] [PubMed] [Google Scholar]
  14. Leerhoy J. Neutralizing antibody to rubella virus in sera collected in Denmark. Dan Med Bull. 1968 Nov;15(9):273–276. [PubMed] [Google Scholar]
  15. Lundström R., Svedmyr A., Hagbard L., Kaijser K. Rubella immunity as related to age and history of overt disease. Acta Paediatr Scand. 1967 May;56(3):279–285. doi: 10.1111/j.1651-2227.1967.tb15378.x. [DOI] [PubMed] [Google Scholar]
  16. Majer R. Röteln. Epidemiologische Untersuchungen und Erfahrungen mit einem attenuierten Impfstoff ("Cendehill strain") Helv Paediatr Acta. 1967 Dec;22(6):579–590. [PubMed] [Google Scholar]
  17. Miller C. L., Miller E., Sequeira P. J., Cradock-Watson J. E., Longson M., Wiseberg E. C. Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J (Clin Res Ed) 1985 Nov 16;291(6506):1398–1401. doi: 10.1136/bmj.291.6506.1398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Miller E. Measles, mumps and rubella: present and future immunisation policy. Public Health. 1988 Jul;102(4):317–321. doi: 10.1016/s0033-3506(88)80100-8. [DOI] [PubMed] [Google Scholar]
  19. Morgan-Capner P., Wright J., Miller C. L., Miller E. Surveillance of antibody to measles, mumps, and rubella by age. BMJ. 1988 Sep 24;297(6651):770–772. doi: 10.1136/bmj.297.6651.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rabo E., Taranger J. Scandinavian model for eliminating measles, mumps, and rubella. Br Med J (Clin Res Ed) 1984 Nov 24;289(6456):1402–1404. doi: 10.1136/bmj.289.6456.1402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rawls W. E., Melnick J. L., Bradstreet C. M., Bailey M., Ferris A. A., Lehmann N. I., Nagler F. P., Furesz J., Kono R., Ohtawara M. WHO collaborative study on the sero-epidemiology of rubella. Bull World Health Organ. 1967;37(1):79–88. [PMC free article] [PubMed] [Google Scholar]
  22. Rudnicka H. Epidemiologia rózyczki w Polsce. Przegl Epidemiol. 1977;31(3):261–274. [PubMed] [Google Scholar]
  23. Svedmyr A. Acquisition and decline of rubella immunity. Problem of reinfections. Am J Dis Child. 1969 Jul;118(1):137–138. doi: 10.1001/archpedi.1969.02100040139022. [DOI] [PubMed] [Google Scholar]
  24. Tóth M. Incidence of rubella virus neutralizing antibody in different age groups. Acta Microbiol Acad Sci Hung. 1968;15(2):119–124. [PubMed] [Google Scholar]
  25. Ukkonen P., von Bonsdorff C. H. Rubella immunity and morbidity: effects of vaccination in Finland. Scand J Infect Dis. 1988;20(3):255–259. doi: 10.3109/00365548809032448. [DOI] [PubMed] [Google Scholar]
  26. Witte J. J., Karchmer A. W., Case G., Herrmann K. L., Abrutyn E., Kassanoff I., Neill J. S. Epidemiology of rubella. Am J Dis Child. 1969 Jul;118(1):107–111. doi: 10.1001/archpedi.1969.02100040109018. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES